Advertisement

Treatment of Upper Urothelial Cell Carcinoma

  • Bum Sik Tae
  • Chang Wook JeongEmail author
Chapter

Abstract

The gold standard for management of UTUC is radical nephroureterectomy (RNU). However, a large number of patients with UTUC have poor comorbidity and may experience serious complications after RNU. Thus, nephron-sparing treatment has been recently attempted in cases of low risk UTUC, especially in patients with low renal function and poor comorbidity.

Keywords

Upper urothelial cell carcinoma Treatment Surgery Management 

References

  1. 1.
    Roupret M, Babjuk M, Comperat E, Zigeuner R, Sylvester RJ, Burger M, et al. European association of urology guidelines on upper urinary tract urothelial carcinoma: 2017 update. Eur Urol. 2018;73:111.CrossRefGoogle Scholar
  2. 2.
    Matin SF, Margulis V, Kamat A, Wood CG, Grossman HB, Brown GA, et al. Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma. Cancer. 2010;116:3127–34.CrossRefGoogle Scholar
  3. 3.
    Porten S, Siefker-Radtke AO, Xiao L, Margulis V, Kamat AM, Wood CG, et al. Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma. Cancer. 2014;120:1794–9.CrossRefGoogle Scholar
  4. 4.
    Hosogoe S, Hatakeyama S, Kusaka A, Hamano I, Iwamura H, Fujita N, et al. Platinum-based neoadjuvant chemotherapy improves oncological outcomes in patients with locally advanced upper tract urothelial carcinoma. Eur Urol Focus. 2017.  https://doi.org/10.1016/j.euf.2017.03.013.CrossRefGoogle Scholar
  5. 5.
    Gayed BA, Thoreson GR, Margulis V. The role of systemic chemotherapy in management of upper tract urothelial cancer. Curr Urol Rep. 2013;14:94–101.CrossRefGoogle Scholar
  6. 6.
    Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA. Campbell-Walsh urology: expert consult premium edition: enhanced online features and print, 4-volume set. Amsterdam: Elsevier; 2011.Google Scholar
  7. 7.
    Jones JS, Gill IS, Klein EA, Rackley RR, Ross JH. Operative urology at the Cleveland clinic. Totowa: Humana Press; 2006.Google Scholar
  8. 8.
    Ariane MM, Colin P, Ouzzane A, Pignot G, Audouin M, Cornu JN, et al. Assessment of oncologic control obtained after open versus laparoscopic nephroureterectomy for upper urinary tract urothelial carcinomas (UUT-UCs): results from a large French multicenter collaborative study. Ann Surg Oncol. 2012;19:301–8.CrossRefGoogle Scholar
  9. 9.
    Adibi M, Youssef R, Shariat SF, Lotan Y, Wood CG, Sagalowsky AI, et al. Oncological outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: comparison over the three decades. Int J Urol. 2012;19:1060–6.CrossRefGoogle Scholar
  10. 10.
    Roupret M, Hupertan V, Sanderson KM, Harmon JD, Cathelineau X, Barret E, et al. Oncologic control after open or laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: a single center experience. Urology. 2007;69:656–61.CrossRefGoogle Scholar
  11. 11.
    Capitanio U, Shariat SF, Isbarn H, Weizer A, Remzi M, Roscigno M, et al. Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases. Eur Urol. 2009;56:1–9.CrossRefGoogle Scholar
  12. 12.
    Simone G, Papalia R, Guaglianone S, Ferriero M, Leonardo C, Forastiere E, et al. Laparoscopic versus open nephroureterectomy: perioperative and oncologic outcomes from a randomised prospective study. Eur Urol. 2009;56:520–6.CrossRefGoogle Scholar
  13. 13.
    Hu JC, Silletti JP, Williams SB. Initial experience with robot-assisted minimally-invasive nephroureterectomy. J Endourol. 2008;22:699–704.CrossRefGoogle Scholar
  14. 14.
    Argun OB, Mourmouris P, Tufek I, Tuna MB, Keskin S, Obek C, et al. Radical nephroureterectomy without patient or port repositioning using the Da Vinci Xi robotic system: initial experience. Urology. 2016;92:136–9.CrossRefGoogle Scholar
  15. 15.
    Matin SF, Gill IS. Recurrence and survival following laparoscopic radical nephroureterectomy with various forms of bladder cuff control. J Urol. 2005;173:395–400.CrossRefGoogle Scholar
  16. 16.
    Macejko AM, Pazona JF, Loeb S, Kimm S, Nadler RB. Management of distal ureter in laparoscopic nephroureterectomy--a comprehensive review of techniques. Urology. 2008;72:974–81.CrossRefGoogle Scholar
  17. 17.
    Saika T, Nishiguchi J, Tsushima T, Nasu Y, Nagai A, Miyaji Y, et al. Comparative study of ureteral stripping versus open ureterectomy for nephroureterectomy in patients with transitional carcinoma of the renal pelvis. Urology. 2004;63:848–52.CrossRefGoogle Scholar
  18. 18.
    Lughezzani G, Burger M, Margulis V, Matin SF, Novara G, Roupret M, et al. Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature. Eur Urol. 2012;62:100–14.CrossRefGoogle Scholar
  19. 19.
    Marshall FF. Laparoscopic radical nephroureterectomy: dilemma of the distal ureter. J Urol. 2005;173:729.PubMedGoogle Scholar
  20. 20.
    Kawauchi A, Fujito A, Ukimura O, Yoneda K, Mizutani Y, Miki T. Hand assisted retroperitoneoscopic nephroureterectomy: comparison with the open procedure. J Urol. 2003;169:890–4. discussion 4.CrossRefGoogle Scholar
  21. 21.
    Gonzalez CM, Batler RA, Schoor RA, Hairston JC, Nadler RB. A novel endoscopic approach towards resection of the distal ureter with surrounding bladder cuff during hand assisted laparoscopic nephroureterectomy. J Urol. 2001;165:483–5.CrossRefGoogle Scholar
  22. 22.
    Vardi IY, Stern JA, Gonzalez CM, Kimm SY, Nadler RB. Novel technique for management of distal ureter and en block resection of bladder cuff during hand-assisted laparoscopic nephroureterectomy. Urology. 2006;67:89–92.CrossRefGoogle Scholar
  23. 23.
    Gill IS, Soble JJ, Miller SD, Sung GT. A novel technique for management of the en bloc bladder cuff and distal ureter during laparoscopic nephroureterectomy. J Urol. 1999;161:430–4.CrossRefGoogle Scholar
  24. 24.
    Tae BS, Choi H, Park JY, Bae JH. Laparoscopic approach for intravesical surgery using pneumovesicum in urology: literature review. Int Neurourol J. 2018;22:S10–22.CrossRefGoogle Scholar
  25. 25.
    Cheng CW, Ng CF, Mak SK, Chan SY, Wong YF, Chan CK, et al. Pneumovesicum method in en-Bloc laparoscopic nephroureterectomy with bladder cuff resection for upper-tract urothelial cancer. J Endourol. 2007;21:359–63. discussion 62–3.CrossRefGoogle Scholar
  26. 26.
    Kutikov A, Guzzo TJ, Canter DJ, Casale P. Initial experience with laparoscopic transvesical ureteral reimplantation at the Children’s Hospital of Philadelphia. J Urol. 2006;176:2222–5. discussion 5–6.CrossRefGoogle Scholar
  27. 27.
    Kondo T, Hashimoto Y, Kobayashi H, Iizuka J, Nakazawa H, Ito F, et al. Template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract: impact on patient survival. Int J Urol. 2010;17:848–54.CrossRefGoogle Scholar
  28. 28.
    Moschini M, Foerster B, Abufaraj M, Soria F, Seisen T, Roupret M, et al. Trends of lymphadenectomy in upper tract urothelial carcinoma (UTUC) patients treated with radical nephroureterectomy. World J Urol. 2017;35:1541–7.CrossRefGoogle Scholar
  29. 29.
    Messer J, Lin YK, Raman JD. The role of lymphadenectomy for upper tract urothelial carcinoma. Nat Rev Urol. 2011;8:394–401.CrossRefGoogle Scholar
  30. 30.
    Roscigno M, Brausi M, Heidenreich A, Lotan Y, Margulis V, Shariat SF, et al. Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer. Eur Urol. 2011;60:776–83.CrossRefGoogle Scholar
  31. 31.
    Roscigno M, Shariat SF, Margulis V, Karakiewicz P, Remzi M, Kikuchi E, et al. Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. J Urol. 2009;181:2482–9.CrossRefGoogle Scholar
  32. 32.
    Bolenz C, Shariat SF, Fernandez MI, Margulis V, Lotan Y, Karakiewicz P, et al. Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node density. BJU Int. 2009;103:302–6.CrossRefGoogle Scholar
  33. 33.
    Komatsu H, Tanabe N, Kubodera S, Maezawa H, Ueno A. The role of lymphadenectomy in the treatment of transitional cell carcinoma of the upper urinary tract. J Urol. 1997;157:1622–4.CrossRefGoogle Scholar
  34. 34.
    Miyake H, Hara I, Gohji K, Arakawa S, Kamidono S. The significance of lymphadenectomy in transitional cell carcinoma of the upper urinary tract. Br J Urol. 1998;82:494–8.CrossRefGoogle Scholar
  35. 35.
    Roscigno M, Cozzarini C, Bertini R, Scattoni V, Freschi M, Da Pozzo LF, et al. Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract. Eur Urol. 2008;53:794–802.CrossRefGoogle Scholar
  36. 36.
    Stein JP, Cai J, Groshen S, Skinner DG. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. J Urol. 2003;170:35–41.CrossRefGoogle Scholar
  37. 37.
    Koppie TM, Vickers AJ, Vora K, Dalbagni G, Bochner BH. Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed? Cancer. 2006;107:2368–74.CrossRefGoogle Scholar
  38. 38.
    Raman JD. Kidney sparing surgery for upper-tract urothelial carcinoma. Minerva Urol Nefrol. 2016;68:359–71.PubMedGoogle Scholar
  39. 39.
    Seisen T, Colin P, Roupret M. Risk-adapted strategy for the kidney-sparing management of upper tract tumours. Nat Rev Urol. 2015;12:155–66.CrossRefGoogle Scholar
  40. 40.
    Clements T, Messer JC, Terrell JD, Herman MP, Ng CK, Scherr DS, et al. High-grade ureteroscopic biopsy is associated with advanced pathology of upper-tract urothelial carcinoma tumors at definitive surgical resection. J Endourol. 2012;26:398–402.CrossRefGoogle Scholar
  41. 41.
    Raman JD, Park R. Endoscopic management of upper-tract urothelial carcinoma. Expert Rev Anticancer Ther. 2017;17:545–54.CrossRefGoogle Scholar
  42. 42.
    Fang D, Xiong G, Li X, Kang Y, Zhang L, Zhao G, et al. Incidence, characteristics, treatment strategies, and oncologic outcomes of synchronous bilateral upper tract urothelial carcinoma in the Chinese population. Urol Oncol. 2015;33:66.e1–11.CrossRefGoogle Scholar
  43. 43.
    Auge BK, Pietrow PK, Lallas CD, Raj GV, Santa-Cruz RW, Preminger GM. Ureteral access sheath provides protection against elevated renal pressures during routine flexible ureteroscopic stone manipulation. J Endourol. 2004;18:33–6.CrossRefGoogle Scholar
  44. 44.
    Kleinmann N, Healy KA, Hubosky SG, Margel D, Bibbo M, Bagley DH. Ureteroscopic biopsy of upper tract urothelial carcinoma: comparison of basket and forceps. J Endourol. 2013;27:1450–4.CrossRefGoogle Scholar
  45. 45.
    Fiuk JV, Schwartz BF. Upper tract urothelial carcinoma: Paradigm shift towards nephron sparing management. World J Nephrol. 2016;5:158–65.CrossRefGoogle Scholar
  46. 46.
    Motamedinia P, Hoenig D, Okeke Z, Smith A. A case for nephron sparing surgery in the management of upper tract urothelial carcinoma. J Endourol. 2016;30(Suppl 1):S18–22.CrossRefGoogle Scholar
  47. 47.
    Suriano F, Brancato T. Nephron-sparing management of upper tract urothelial carcinoma. Rev Urol. 2014;16:21–8.PubMedPubMedCentralGoogle Scholar
  48. 48.
    Audenet F, Traxer O, Bensalah K, Roupret M. Upper urinary tract instillations in the treatment of urothelial carcinomas: a review of technical constraints and outcomes. World J Urol. 2013;31:45–52.CrossRefGoogle Scholar
  49. 49.
    Thalmann GN, Markwalder R, Walter B, Studer UE. Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery. J Urol. 2002;168:1381–5.CrossRefGoogle Scholar
  50. 50.
    Irie A, Iwamura M, Kadowaki K, Ohkawa A, Uchida T, Baba S. Intravesical instillation of bacille Calmette-Guerin for carcinoma in situ of the urothelium involving the upper urinary tract using vesicoureteral reflux created by a double-pigtail catheter. Urology. 2002;59:53–7.CrossRefGoogle Scholar
  51. 51.
    Schneider B, Thanhauser A, Jocham D, Loppnow H, Vollmer E, Galle J, et al. Specific binding of bacillus Calmette-Guerin to urothelial tumor cells in vitro. World J Urol. 1994;12:337–44.CrossRefGoogle Scholar
  52. 52.
    Seisen T, Granger B, Colin P, Leon P, Utard G, Renard-Penna R, et al. A systematic review and meta-analysis of clinicopathologic factors linked to intravesical recurrence after radical nephroureterectomy to treat upper tract urothelial carcinoma. Eur Urol. 2015;67:1122–33.CrossRefGoogle Scholar
  53. 53.
    Ito A, Shintaku I, Satoh M, Ioritani N, Aizawa M, Tochigi T, et al. Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group Trial. J Clin Oncol. 2013;31:1422–7.CrossRefGoogle Scholar
  54. 54.
    O'Brien T, Ray E, Singh R, Coker B, Beard R. Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial). Eur Urol. 2011;60:703–10.CrossRefGoogle Scholar
  55. 55.
    Wu P, Zhu G, Wei D, Liu S, Walsh K, Li D, et al. Prophylactic intravesical chemotherapy decreases bladder tumor recurrence after nephroureterectomy for primary upper tract urothelial carcinoma: A systematic review and meta-analysis. J BUON. 2015;20:1229–38.PubMedGoogle Scholar
  56. 56.
    Fang D, Li XS, Xiong GY, Yao L, He ZS, Zhou LQ. Prophylactic intravesical chemotherapy to prevent bladder tumors after nephroureterectomy for primary upper urinary tract urothelial carcinomas: a systematic review and meta-analysis. Urol Int. 2013;91:291–6.CrossRefGoogle Scholar
  57. 57.
    Seisen T, Jindal T, Karabon P, Sood A, Bellmunt J, Roupret M, et al. Efficacy of systemic chemotherapy plus radical nephroureterectomy for metastatic upper tract urothelial carcinoma. Eur Urol. 2017;71:714–8.CrossRefGoogle Scholar
  58. 58.
    Brookland RK, Richter MP. The postoperative irradiation of transitional cell carcinoma of the renal pelvis and ureter. J Urol. 1985;133:952–5.CrossRefGoogle Scholar
  59. 59.
    Catton CN, Warde P, Gospodarowicz MK, Panzarella T, Catton P, McLean M, et al. Transitional cell carcinoma of the renal pelvis and ureter: Outcome and patterns of relapse in patients treated with postoperative radiation. Urol Oncol. 1996;2:171–6.CrossRefGoogle Scholar
  60. 60.
    Chen B, Zeng ZC, Wang GM, Zhang L, Lin ZM, Sun LA, et al. Radiotherapy may improve overall survival of patients with T3/T4 transitional cell carcinoma of the renal pelvis or ureter and delay bladder tumour relapse. BMC Cancer. 2011;11:297.CrossRefGoogle Scholar
  61. 61.
    Cozad SC, Smalley SR, Austenfeld M, Noble M, Jennings S, Raymond R. Transitional cell carcinoma of the renal pelvis or ureter: patterns of failure. Urology. 1995;46:796–800.CrossRefGoogle Scholar
  62. 62.
    Czito B, Zietman A, Kaufman D, Skowronski U, Shipley W. Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter. J Urol. 2004;172:1271–5.CrossRefGoogle Scholar
  63. 63.
    Hall MC, Womack JS, Roehrborn CG, Carmody T, Sagalowsky AI. Advanced transitional cell carcinoma of the upper urinary tract: patterns of failure, survival and impact of postoperative adjuvant radiotherapy. J Urol. 1998;160:703–6.CrossRefGoogle Scholar
  64. 64.
    Jwa E, Kim YS, Ahn H, Kim CS, Lee JL, Kim SO, et al. Adjuvant radiotherapy for stage III/IV urothelial carcinoma of the upper tract. Anticancer Res. 2014;34:333–8.PubMedGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  1. 1.Korea University College of MedicineSeoulSouth Korea
  2. 2.Department UrologyKorea University Ansan HospitalAnsanSouth Korea
  3. 3.Department UrologySeoul National University HospitalSeoulSouth Korea

Personalised recommendations